Jeffrey M. Rowe serves as Executive at Diplomat Pharmacy, Inc., where they oversee executive responsibilities. Since joining the company, Jeffrey M. Rowe has executed 7 insider transactions totaling $29.9M, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 29, 2018 involved exercising options for 175,000 shares valued at $210.0K.
Jeffrey M. Rowe currently holds 275,000 shares of Diplomat Pharmacy, Inc. (DPLO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jeffrey M. Rowe has been a net seller of DPLO stock. They have purchased $0 and sold $29.9M worth of shares.
Jeffrey M. Rowe's most recent insider trade was on Nov 29, 2018, when they sold 175,000 shares at $1.20 per share.
Get notified when new Form 4 filings are submitted
| 100,000 |
| $0.20 |
| Discretionary |
| Mar 25, 2015 | DPLO | $17.4M | Sale | 600,000 | $29.00 | Discretionary |
| Oct 9, 2014 | DPLO | $3.5M | Sale | 270,833 | $13.00 | Discretionary |
| Oct 9, 2014 | DPLO | $3.5M | Sale | 270,833 | $13.00 | Discretionary |
| Oct 9, 2014 | DPLO | $2.7M | Sale | 208,333 | $13.00 | Discretionary |
| Oct 9, 2014 | DPLO | $2.7M | Sale | 208,333 | $13.00 | Discretionary |